Diabetes may become more common with age because of a decline in the function of mitochondria, the powerhouses of the body’s cells.
Read More »Diabetes In Control
Issue 151 Item 10 Glitazones and Insulin: A Combination with Known Risks
More type 2 diabetes patients will get a “glitazone” along with insulin, now that Avandia (rosiglitazone) and Actos (pioglitazone) are both APPROVED for use with insulin.
Read More »Issue 153 Item 7 E-Counseling Helps Pre-Diabetes Adults Lose Weight
Individuals who received e-counseling lost 4.8% of their original body weight after participating in the Internet program, almost double the weight loss experienced by individuals who were not counseled.
Read More »Coffee Reduces the Risk For Type 2 Diabetes and Alzheimer’s Dis
Every day, millions of Americans start the day with a cup of coffee and they drink it mostly for the same reason.
Read More »Symlin Passes Test for Glucose Control with FDA Gets Closer to
The test showed that people with Type 1, or childhood-onset diabetes, who take insulin daily were better able to control their blood glucose when they also took Symlin.
Read More »Poorly Controlled Diabetes Could Lead to Dementia in Elderly
Poorly controlled diabetes seems to cause cognitive problems in the elderly, a new study reports.
Read More »Issue 152 Item 5 Different Aspects of Impaired Glucose Tolerance and Fasting Glu
People with isolated IFG were more resistant to insulin than people with IGT, and that people with isolated IGT showed a greater deficiency in the early and late stages of insulin secretion.
Read More »Issue 157 Item 12 Repaglinide + Metformin Vs. Nateglinide + Metformin in Treatin
Patients with type 2 diabetes have significantly better fasting plasma glucose levels (FPG) and hemoglobin A1c (HbA1c) levels when treated with metformin combined with repaglinide rather than combined with nateglinide.
Read More »Issue 150 Item 2 New Physician Guidelines Emphasize Blood Pressure Control in Ma
Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in patients with type 2 diabetes.
Read More »Issue 154 Item 1 Long-Term Enalapril Slows Disease Damage In Diabetics
Enalapril treatment resulted in an absolute risk reduction of 22.4 percentage points for the development of clinical albuminuria over five years.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.